Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33704
Title: Multimodal intrathecal analgesia (MITA) with morphine for reducing postoperative opioid use and acute pain following hepato-pancreato-biliary surgery: A multicenter retrospective study.
Austin Authors: Ratnasekara, Vidhura;Weinberg, Laurence ;Johnston, Samuel Anthony;Fletcher, Luke R ;Nugraha, Patrick;Cox, Daniel Robert Anthony;Hu, Raymond T C ;Meyer, Ilonka;Yoshino, Osamu ;Perini, Marcos Vinius;Muralidharan, Vijayaragavan ;Nikfarjam, Mehrdad ;Lee, Dong-Kyu
Affiliation: Anaesthesia
Department of Critical Care, The University of Melbourne, Austin Health, Heidelberg, Australia.
Data Analytics Research and Evaluation (DARE) Centre
Surgery (University of Melbourne)
Department of Anesthesiology and Pain Medicine, Dongguk University Ilsan Hospital, Goyang, Republic of Korea.
Issue Date: 2023
Date: 2023
Publication information: PloS One 2023; 18(9)
Abstract: The optimal analgesic modality for patients undergoing hepato-pancreato-biliary (HPB) surgery remains unknown. The analgesic effects of a multimodal intrathecal analgesia (MITA) technique of intrathecal morphine (ITM) in combination with clonidine and bupivacaine compared to ITM alone have not been investigated in these patients. We performed a multicenter retrospective study of patients undergoing complex HPB surgery who received ITM, bupivacaine, and clonidine (MITA group) or ITM-only (ITM group) as part of their perioperative analgesia strategy. The primary outcome was the unadjusted oral morphine equivalent daily dose (oMEDD) in milligrams on postoperative day 1. After adjusting for age, body mass index, hospital allocation, type of surgery, operation length, and intraoperative opioid use, postoperative oMEDD use was investigated using a bootstrapped quantile regression model. Other prespecified outcomes included postoperative pain scores, opioid-related adverse events, major complications, and length of hospital stay. In total, 118 patients received MITA and 155 patients received ITM-only. The median (IQR) cumulative oMEDD use on postoperative day 1 was 20.5 mg (8.6:31.0) in the MITA group and 52.1 mg (18.0:107.0) in the ITM group (P < 0.001). There was a variation in the magnitude of the difference in oMEDD use between the groups for different quartiles. For the MITA group, on postoperative day 1, patients in the 25th percentile required 14.0 mg less oMEDD (95% CI: -25.9 to -2.2; P = 0.025), patients in the 50th percentile required 27.8 mg less oMEDD (95% CI: -49.7 to -6.0; P = 0.005), and patients in the 75th percentile required 38.7 mg less oMEDD (95% CI: -72.2 to -5.1; P = 0.041) compared to patients in the same percentile of the ITM group. Patients in the MITA group had significantly lower pain scores in the postoperative recovery unit and on postoperative days 1 to 3. The incidence of postoperative respiratory depression was low (<1.5%) and similar between groups. Patients in the MITA group had a significantly higher incidence of postoperative hypotension requiring vasopressor support. However, no significant differences were observed in major postoperative complications, or the length of hospital stay. In patients undergoing complex HPB surgery, the use of MITA, consisting of ITM in combination with intrathecal clonidine and bupivacaine, was associated with reduced postoperative opioid use and resulted in superior postoperative analgesia without risk of respiratory depression when compared to patients who received ITM alone. A randomized prospective clinical trial investigating these two intrathecal analgesic techniques is justified.
URI: https://ahro.austin.org.au/austinjspui/handle/1/33704
DOI: 10.1371/journal.pone.0291108
ORCID: 0000-0001-7403-7680
0000-0002-1352-4255
0000-0002-1146-763X
0009-0009-9968-6754
0000-0002-5092-4370
0000-0002-0169-0600
0000-0002-8025-9519
0000-0001-8247-8937
Journal: PloS One
Start page: e0291108
PubMed URL: 37682837
ISSN: 1932-6203
Type: Journal Article
Subjects: Analgesics, Opioid/therapeutic use
Morphine/adverse effects
Clonidine/therapeutic use
Bupivacaine/therapeutic use
Appears in Collections:Journal articles

Show full item record

Page view(s)

40
checked on Jul 4, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.